Sign up
Pharma Capital
EPIC: SUMM
Market: AIM
Sector: Pharma & Biotech
Market Cap: 31.57M

We are seeking to treat all boys and young men afflicted with the fatal disease Duchenne muscular dystrophy with our pioneering utrophin modulation technology.

We are also advancing a highly selective novel antibiotic for C. difficile infection.

Summit Therapeutics PLC

www.summitplc.com

Interactive graph

col 3
col 4
col 5
col 6

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.